Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C5H3N5O2S3 |
| Molecular Weight | 261.305 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NN=C(SC2=NC=C(S2)[N+]([O-])=O)S1
InChI
InChIKey=NQQBNZBOOHHVQP-UHFFFAOYSA-N
InChI=1S/C5H3N5O2S3/c6-3-8-9-5(14-3)15-4-7-1-2(13-4)10(11)12/h1H,(H2,6,8)
| Molecular Formula | C5H3N5O2S3 |
| Molecular Weight | 261.305 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2096667 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19271755 |
0.7 µM [IC50] |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:44:16 GMT 2025
by
admin
on
Wed Apr 02 08:44:16 GMT 2025
|
| Record UNII |
Y4KQC5P9B2
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID70474254
Created by
admin on Wed Apr 02 08:44:16 GMT 2025 , Edited by admin on Wed Apr 02 08:44:16 GMT 2025
|
PRIMARY | |||
|
40045-50-9
Created by
admin on Wed Apr 02 08:44:16 GMT 2025 , Edited by admin on Wed Apr 02 08:44:16 GMT 2025
|
PRIMARY | |||
|
Y4KQC5P9B2
Created by
admin on Wed Apr 02 08:44:16 GMT 2025 , Edited by admin on Wed Apr 02 08:44:16 GMT 2025
|
PRIMARY | |||
|
11837140
Created by
admin on Wed Apr 02 08:44:16 GMT 2025 , Edited by admin on Wed Apr 02 08:44:16 GMT 2025
|
PRIMARY | |||
|
Halicin
Created by
admin on Wed Apr 02 08:44:16 GMT 2025 , Edited by admin on Wed Apr 02 08:44:16 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
Retained bactericidal activity against antibiotic-tolerant E. coli and M. tuberculosis, as well as growth inhibitory properties against multidrug resistant Gram-negative clinical isolates. Dissipates the DpH Component of the Proton
Motive Force
|